Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy.
The toxicological effects of realgar after intragastrical administration (1 g/kg body weight) were investigated over a 21 day period in male Wistar rats using metabonomic analysis of (1)H NMR spectra of urine, serum and liver tissue aqueous extracts. Liver and kidney histopathology examination and serum clinical chemistry analyses were also performed. (1)H NMR spectra and pattern recognition analyses from realgar treated animals showed increased excretion of urinary Kreb's cycle intermediates, increased levels of ketone bodies in urine and serum, and decreased levels of hepatic glucose and glycogen, as well as hypoglycemia and hyperlipoidemia, suggesting the perturbation of energy metabolism. Elevated levels of choline containing metabolites and betaine in serum and liver tissue aqueous extracts and increased serum creatine indicated altered transmethylation. Decreased urinary levels of trimethylamine-N-oxide, phenylacetylglycine and hippurate suggested the effects on the gut microflora environment by realgar. Signs of impairment of amino acid metabolism were supported by increased hepatic glutamate levels, increased methionine and decreased alanine levels in serum, and hypertaurinuria. The observed increase in glutathione in liver tissue aqueous extracts could be a biomarker of realgar induced oxidative injury. Serum clinical chemistry analyses showed increased levels of lactate dehydrogenase, aspartate aminotransferase, and alkaline phosphatase as well as increased levels of blood urea nitrogen and creatinine, indicating slight liver and kidney injury. The time-dependent biochemical variations induced by realgar were achieved using pattern recognition methods. This work illustrated the high reliability of NMR-based metabonomic approach on the study of the biochemical effects induced by traditional Chinese medicine.
Wei
Lai
L
Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, PR China.
Liao
Peiqiu
P
Wu
Huifeng
H
Li
Xiaojing
X
Pei
Fengkui
F
Li
Weisheng
W
Wu
Yijie
Y
D000818:Animals; D001152:Arsenicals / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001774:Blood Chemical Analysis; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000633:toxicity*; D004734:Energy Metabolism / Q000187:drug effects*; D007422:Intestines / Q000187:drug effects / Q000382:microbiology; D007441:Intubation, Gastrointestinal; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D055432:Metabolomics / Q000379:methods*; D010363:Pattern Recognition, Automated; D025341:Principal Component Analysis; D051381:Rats; D017208:Rats, Wistar; D015203:Reproducibility of Results; D013440:Sulfides / Q000008:administration & dosage / Q000633:toxicity*; D013997:Time Factors; D016482:Urinalysis
D001152:Arsenicals; D015415:Biomarkers; D004365:Drugs, Chinese Herbal; D013440:Sulfides; C058317:arsenic disulfide